Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$0.92 - $1.28 $13,688 - $19,045
14,879 New
14,879 $17,000
Q1 2023

May 01, 2023

BUY
$0.59 - $1.18 $44,391 - $88,783
75,240 New
75,240 $48,000
Q2 2022

Aug 09, 2022

SELL
$0.47 - $0.7 $15,690 - $23,369
-33,385 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$0.57 - $0.88 $14,051 - $21,693
-24,652 Reduced 42.48%
33,385 $23,000
Q4 2021

Feb 17, 2022

BUY
$0.56 - $1.26 $18,725 - $42,131
33,438 Added 135.93%
58,037 $33,000
Q3 2021

Nov 12, 2021

SELL
$1.05 - $2.0 $12,614 - $24,028
-12,014 Reduced 32.81%
24,599 $27,000
Q2 2021

Sep 17, 2021

BUY
$1.38 - $2.46 $50,525 - $90,067
36,613 New
36,613 $60,000
Q4 2020

Feb 24, 2021

SELL
$0.82 - $1.63 $17,780 - $35,344
-21,684 Closed
0 $0
Q3 2020

Dec 11, 2020

BUY
$0.76 - $1.6 $16,479 - $34,694
21,684 New
21,684 $18,000

Others Institutions Holding XTNT

About Xtant Medical Holdings, Inc.


  • Ticker XTNT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 108,226,000
  • Market Cap $40M
  • Description
  • Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...
More about XTNT
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.